View ValuationCreotech Instruments 将来の成長Future 基準チェック /06現在、 Creotech Instrumentsの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Aerospace & Defense 収益成長11.1%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Jun 11Creotech Instruments S.A. has completed a Follow-on Equity Offering in the amount of €481 million.Creotech Instruments S.A. has completed a Follow-on Equity Offering in the amount of €481 million. Security Name: Series M Ordinary Bearer Shares Security Type: Common Stock Securities Offered: 650,000 Price\Range: €740 Transaction Features: Regulation S; Subsequent Direct ListingReported Earnings • Jun 05First quarter 2026 earnings released: zł2.95 loss per share (vs zł0.59 profit in 1Q 2025)First quarter 2026 results: zł2.95 loss per share (down from zł0.59 profit in 1Q 2025). Revenue: zł18.0m (down 30% from 1Q 2025). Net loss: zł8.41m (down zł9.82m from profit in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has increased by 65% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • May 08Creotech Instruments S.A., Annual General Meeting, Jun 03, 2026Creotech Instruments S.A., Annual General Meeting, Jun 03, 2026, at 14:00 Central European Standard Time.お知らせ • Apr 04Creotech Instruments S.A. (WSE:CRI) completed the Spin-Off of Creotech Quantum S.A.Creotech Instruments S.A. (WSE:CRI) agreed to Spin-Off Quantum segments on April 17, 2025. As part of the spinoff, Creotech Instruments shareholders will be allocated shares in the new quantum company in proportion to their holdings. The allocation of shares will take place through a public offering of shares. The quantum company is expected to go public on the WSE, at the same time, a new company will be created to focus on the development and commercialization of quantum systems so far developed at Creotech and assuming the prospectus procedure before Poland's financial market regulator KNF and the receival of all corporate approvals proceeds without delay and the spinoff proposal receives the approval of the shareholders. The estimated date for concluding the spinoff is late 2025/early 2026. Creotech Instruments S.A. (WSE:CRI) completed the Spin-Off of Creotech Quantum S.A. on April 2, 2026. Final record date for entitlement to the distribution is April 2, 2026. Creotech Quantum debut on WSE scheduled for April 17, 2026.New Risk • Feb 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Polish stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 45% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.3% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding).分析記事 • Jan 13Investors Appear Satisfied With Creotech Instruments S.A.'s (WSE:CRI) Prospects As Shares Rocket 28%The Creotech Instruments S.A. ( WSE:CRI ) share price has done very well over the last month, posting an excellent gain...New Risk • Oct 07New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 20% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 52% per year over the past 5 years. Minor Risk Shareholders have been diluted in the past year (20% increase in shares outstanding).分析記事 • Sep 30Revenues Tell The Story For Creotech Instruments S.A. (WSE:CRI) As Its Stock Soars 28%Creotech Instruments S.A. ( WSE:CRI ) shareholders have had their patience rewarded with a 28% share price jump in the...Reported Earnings • Sep 28Second quarter 2025 earnings released: EPS: zł0.77 (vs zł1.77 loss in 2Q 2024)Second quarter 2025 results: EPS: zł0.77 (up from zł1.77 loss in 2Q 2024). Revenue: zł48.9m (up 487% from 2Q 2024). Net income: zł2.14m (up zł6.35m from 2Q 2024). Profit margin: 4.4% (up from net loss in 2Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 42% per year, which means it is well ahead of earnings.お知らせ • Aug 25Creotech Instruments S.A. to Report First Half, 2025 Results on Sep 26, 2025Creotech Instruments S.A. announced that they will report first half, 2025 results on Sep 26, 2025分析記事 • Jul 18Here's Why We're Not Too Worried About Creotech Instruments' (WSE:CRI) Cash Burn SituationWe can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...Reported Earnings • Jun 02First quarter 2025 earnings released: EPS: zł0.59 (vs zł1.40 loss in 1Q 2024)First quarter 2025 results: EPS: zł0.59 (up from zł1.40 loss in 1Q 2024). Revenue: zł25.5m (up 191% from 1Q 2024). Net income: zł1.40m (up zł4.74m from 1Q 2024). Profit margin: 5.5% (up from net loss in 1Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 29% per year, which means it is well ahead of earnings.お知らせ • May 19Creotech Instruments S.A., Annual General Meeting, Jun 16, 2025Creotech Instruments S.A., Annual General Meeting, Jun 16, 2025.Reported Earnings • Nov 29Third quarter 2024 earnings released: zł2.94 loss per share (vs zł1.85 loss in 3Q 2023)Third quarter 2024 results: zł2.94 loss per share (further deteriorated from zł1.85 loss in 3Q 2023). Revenue: zł5.86m (down 56% from 3Q 2023). Net loss: zł7.00m (loss widened 92% from 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.分析記事 • Oct 08Creotech Instruments S.A.'s (WSE:CRI) Popularity With Investors Under Threat As Stock Sinks 25%Unfortunately for some shareholders, the Creotech Instruments S.A. ( WSE:CRI ) share price has dived 25% in the last...Reported Earnings • Oct 02Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: zł8.33m (down 11% from 2Q 2023). Net loss: zł4.22m (loss widened 17% from 2Q 2023).New Risk • Sep 30New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: zł381.9m (US$99.2m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.3% average weekly change). Earnings have declined by 92% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (20% increase in shares outstanding). Market cap is less than US$100m (zł381.9m market cap, or US$99.2m).New Risk • Aug 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Polish stocks, typically moving 6.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 8.5% over the past year. Minor Risks Share price has been volatile over the past 3 months (6.5% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding).New Risk • Jun 16New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 8.5% over the past year. Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Shareholders have been diluted in the past year (20% increase in shares outstanding).お知らせ • May 21Creotech Instruments S.A., Annual General Meeting, Jun 24, 2024Creotech Instruments S.A., Annual General Meeting, Jun 24, 2024.New Risk • Feb 13New major risk - Revenue and earnings growthRevenue has declined by 8.5% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 8.5% over the past year. Minor Risk Shareholders have been diluted in the past year (20% increase in shares outstanding).お知らせ • Feb 02+ 3 more updatesCreotech Instruments S.A. to Report First Half, 2024 Results on Sep 27, 2024Creotech Instruments S.A. announced that they will report first half, 2024 results on Sep 27, 2024New Risk • Dec 22New major risk - Revenue and earnings growthRevenue has declined by 22% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 22% over the past year. Minor Risks Share price has been volatile over the past 3 months (7.3% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding).New Risk • Dec 11New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 20% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.2% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding).New Risk • Oct 25New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Polish stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Market cap is less than US$100m (zł412.4m market cap, or US$97.5m).New Risk • Aug 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Polish stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 8.9% over the past year. Minor Risk Share price has been volatile over the past 3 months (7.0% average weekly change).お知らせ • Jun 04Creotech Instruments S.A., Annual General Meeting, Jun 30, 2023Creotech Instruments S.A., Annual General Meeting, Jun 30, 2023, at 10:00 Central European Standard Time.分析記事 • Feb 21Is Creotech Instruments (WSE:CRI) In A Good Position To Invest In Growth?We can readily understand why investors are attracted to unprofitable companies. For example, although...お知らせ • Feb 03+ 2 more updatesCreotech Instruments S.A. to Report Q3, 2023 Results on Nov 27, 2023Creotech Instruments S.A. announced that they will report Q3, 2023 results on Nov 27, 2023Reported Earnings • Nov 27Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: zł4.91m (down 26% from 3Q 2021). Net loss: zł2.24m (down 451% from profit in 3Q 2021).Reported Earnings • Oct 03Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: zł2.59m (down 61% from 2Q 2021). Net loss: zł2.93m (down zł3.57m from profit in 2Q 2021). このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Creotech Instruments は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測WSE:CRI - アナリストの将来予測と過去の財務データ ( )PLN Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/20261469-210N/A12/31/2025150202250N/A9/30/202588-5-1412N/A6/30/202573-61338N/A3/31/202533-12-28-1N/A12/31/202420-18-38-19N/A9/30/202434-20-2-2N/A6/30/202441-1613N/A3/31/202442-16-21N/A12/31/202344-141515N/A9/30/202344-12-714N/A6/30/202338-10-116N/A3/31/202336-9-76N/A12/31/202234-7-19-7N/A9/30/202234-5-24-14N/A6/30/202233-2-18-10N/A3/31/2022330-20-12N/A12/31/2021330-20-11N/A9/30/202129-1-15-4N/A12/31/2020292-80N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: CRIの予測収益成長が 貯蓄率 ( 5.3% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: CRIの収益がPolish市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: CRIの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: CRIの収益がPolish市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: CRIの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: CRIの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YCapital-goods 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/15 18:29終値2026/06/15 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Creotech Instruments S.A. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Jun 11Creotech Instruments S.A. has completed a Follow-on Equity Offering in the amount of €481 million.Creotech Instruments S.A. has completed a Follow-on Equity Offering in the amount of €481 million. Security Name: Series M Ordinary Bearer Shares Security Type: Common Stock Securities Offered: 650,000 Price\Range: €740 Transaction Features: Regulation S; Subsequent Direct Listing
Reported Earnings • Jun 05First quarter 2026 earnings released: zł2.95 loss per share (vs zł0.59 profit in 1Q 2025)First quarter 2026 results: zł2.95 loss per share (down from zł0.59 profit in 1Q 2025). Revenue: zł18.0m (down 30% from 1Q 2025). Net loss: zł8.41m (down zł9.82m from profit in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has increased by 65% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • May 08Creotech Instruments S.A., Annual General Meeting, Jun 03, 2026Creotech Instruments S.A., Annual General Meeting, Jun 03, 2026, at 14:00 Central European Standard Time.
お知らせ • Apr 04Creotech Instruments S.A. (WSE:CRI) completed the Spin-Off of Creotech Quantum S.A.Creotech Instruments S.A. (WSE:CRI) agreed to Spin-Off Quantum segments on April 17, 2025. As part of the spinoff, Creotech Instruments shareholders will be allocated shares in the new quantum company in proportion to their holdings. The allocation of shares will take place through a public offering of shares. The quantum company is expected to go public on the WSE, at the same time, a new company will be created to focus on the development and commercialization of quantum systems so far developed at Creotech and assuming the prospectus procedure before Poland's financial market regulator KNF and the receival of all corporate approvals proceeds without delay and the spinoff proposal receives the approval of the shareholders. The estimated date for concluding the spinoff is late 2025/early 2026. Creotech Instruments S.A. (WSE:CRI) completed the Spin-Off of Creotech Quantum S.A. on April 2, 2026. Final record date for entitlement to the distribution is April 2, 2026. Creotech Quantum debut on WSE scheduled for April 17, 2026.
New Risk • Feb 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Polish stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 45% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.3% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding).
分析記事 • Jan 13Investors Appear Satisfied With Creotech Instruments S.A.'s (WSE:CRI) Prospects As Shares Rocket 28%The Creotech Instruments S.A. ( WSE:CRI ) share price has done very well over the last month, posting an excellent gain...
New Risk • Oct 07New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 20% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 52% per year over the past 5 years. Minor Risk Shareholders have been diluted in the past year (20% increase in shares outstanding).
分析記事 • Sep 30Revenues Tell The Story For Creotech Instruments S.A. (WSE:CRI) As Its Stock Soars 28%Creotech Instruments S.A. ( WSE:CRI ) shareholders have had their patience rewarded with a 28% share price jump in the...
Reported Earnings • Sep 28Second quarter 2025 earnings released: EPS: zł0.77 (vs zł1.77 loss in 2Q 2024)Second quarter 2025 results: EPS: zł0.77 (up from zł1.77 loss in 2Q 2024). Revenue: zł48.9m (up 487% from 2Q 2024). Net income: zł2.14m (up zł6.35m from 2Q 2024). Profit margin: 4.4% (up from net loss in 2Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 42% per year, which means it is well ahead of earnings.
お知らせ • Aug 25Creotech Instruments S.A. to Report First Half, 2025 Results on Sep 26, 2025Creotech Instruments S.A. announced that they will report first half, 2025 results on Sep 26, 2025
分析記事 • Jul 18Here's Why We're Not Too Worried About Creotech Instruments' (WSE:CRI) Cash Burn SituationWe can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Reported Earnings • Jun 02First quarter 2025 earnings released: EPS: zł0.59 (vs zł1.40 loss in 1Q 2024)First quarter 2025 results: EPS: zł0.59 (up from zł1.40 loss in 1Q 2024). Revenue: zł25.5m (up 191% from 1Q 2024). Net income: zł1.40m (up zł4.74m from 1Q 2024). Profit margin: 5.5% (up from net loss in 1Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 29% per year, which means it is well ahead of earnings.
お知らせ • May 19Creotech Instruments S.A., Annual General Meeting, Jun 16, 2025Creotech Instruments S.A., Annual General Meeting, Jun 16, 2025.
Reported Earnings • Nov 29Third quarter 2024 earnings released: zł2.94 loss per share (vs zł1.85 loss in 3Q 2023)Third quarter 2024 results: zł2.94 loss per share (further deteriorated from zł1.85 loss in 3Q 2023). Revenue: zł5.86m (down 56% from 3Q 2023). Net loss: zł7.00m (loss widened 92% from 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.
分析記事 • Oct 08Creotech Instruments S.A.'s (WSE:CRI) Popularity With Investors Under Threat As Stock Sinks 25%Unfortunately for some shareholders, the Creotech Instruments S.A. ( WSE:CRI ) share price has dived 25% in the last...
Reported Earnings • Oct 02Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: zł8.33m (down 11% from 2Q 2023). Net loss: zł4.22m (loss widened 17% from 2Q 2023).
New Risk • Sep 30New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: zł381.9m (US$99.2m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.3% average weekly change). Earnings have declined by 92% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (20% increase in shares outstanding). Market cap is less than US$100m (zł381.9m market cap, or US$99.2m).
New Risk • Aug 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Polish stocks, typically moving 6.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 8.5% over the past year. Minor Risks Share price has been volatile over the past 3 months (6.5% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding).
New Risk • Jun 16New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 8.5% over the past year. Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Shareholders have been diluted in the past year (20% increase in shares outstanding).
お知らせ • May 21Creotech Instruments S.A., Annual General Meeting, Jun 24, 2024Creotech Instruments S.A., Annual General Meeting, Jun 24, 2024.
New Risk • Feb 13New major risk - Revenue and earnings growthRevenue has declined by 8.5% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 8.5% over the past year. Minor Risk Shareholders have been diluted in the past year (20% increase in shares outstanding).
お知らせ • Feb 02+ 3 more updatesCreotech Instruments S.A. to Report First Half, 2024 Results on Sep 27, 2024Creotech Instruments S.A. announced that they will report first half, 2024 results on Sep 27, 2024
New Risk • Dec 22New major risk - Revenue and earnings growthRevenue has declined by 22% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 22% over the past year. Minor Risks Share price has been volatile over the past 3 months (7.3% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding).
New Risk • Dec 11New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 20% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.2% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding).
New Risk • Oct 25New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Polish stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Market cap is less than US$100m (zł412.4m market cap, or US$97.5m).
New Risk • Aug 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Polish stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 8.9% over the past year. Minor Risk Share price has been volatile over the past 3 months (7.0% average weekly change).
お知らせ • Jun 04Creotech Instruments S.A., Annual General Meeting, Jun 30, 2023Creotech Instruments S.A., Annual General Meeting, Jun 30, 2023, at 10:00 Central European Standard Time.
分析記事 • Feb 21Is Creotech Instruments (WSE:CRI) In A Good Position To Invest In Growth?We can readily understand why investors are attracted to unprofitable companies. For example, although...
お知らせ • Feb 03+ 2 more updatesCreotech Instruments S.A. to Report Q3, 2023 Results on Nov 27, 2023Creotech Instruments S.A. announced that they will report Q3, 2023 results on Nov 27, 2023
Reported Earnings • Nov 27Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: zł4.91m (down 26% from 3Q 2021). Net loss: zł2.24m (down 451% from profit in 3Q 2021).
Reported Earnings • Oct 03Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: zł2.59m (down 61% from 2Q 2021). Net loss: zł2.93m (down zł3.57m from profit in 2Q 2021).